We are live on
!
Find out more
BHCM
Brevan Howard Capital Management Portfolio holdings
AUM
$11.3B
1-Year Est. Return
35.84%
This Fund
S&P 500
This Quarter
Est. Return
+11.38%
1 Year Est. Return
+35.84%
3 Year Est. Return
+106.49%
5 Year Est. Return
+80.14%
10 Year Est. Return
–
AUM
$8.18B
AUM Growth
+$422M
(+5.4%)
Cap. Flow
-$70.2M
Cap. Flow
% of AUM
-0.86%
Top 10 Holdings %
Top 10 Hldgs %
80.21%
Holding
1,125
New
743
Increased
197
Reduced
52
Closed
119
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$95.9M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$37.3M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$23M |
| 4 |
Home Depot
HD
|
+$13.3M |
| 5 |
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
|
+$11.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Brazil ETF
EWZ
|
+$30.8M |
| 2 |
CME Group
CME
|
+$20.5M |
| 3 |
Moderna
MRNA
|
+$16.2M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$12.4M |
| 5 |
VMW
VMware, Inc
VMW
|
+$6.85M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 1.72% |
| 2 | Industrials | 1.29% |
| 3 | Consumer Discretionary | 1.28% |
| 4 | Financials | 1.01% |
| 5 | Healthcare | 0.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ITCI
851
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $218K | ﹤0.01% |
+3,039
| New | +$175K |
|
|
RCM
852
DELISTED
R1 RCM Inc. Common Stock
RCM
| $217K | ﹤0.01% |
+20,571
| New | +$233K |
|
853
Sonoco
SON
$5.74B
| $215K | ﹤0.01% |
+3,857
| New | +$209K |
|
854
Fastenal
FAST
$59.5B
| $214K | ﹤0.01% |
+6,594
| New | +$199K |
|
855
Arcturus Therapeutics
ARCT
$211M
| $213K | ﹤0.01% |
+6,749
| New | +$160K |
|
|
REVG
856
DELISTED
REV Group
REVG
| $212K | ﹤0.01% |
+11,679
| New | +$187K |
|
857
Applied Industrial Technologies
AIT
$13.3B
| $210K | ﹤0.01% |
+1,217
| New | +$197K |
|
858
Morgan Stanley
MS
$340B
| $209K | ﹤0.01% |
2,241
-4,155
| -65% | -$332K |
|
859
Trinity Industries
TRN
$2.38B
| $207K | ﹤0.01% |
+7,798
| New | +$187K |
|
860
AnaptysBio
ANAB
$1.68B
| $207K | ﹤0.01% |
+9,673
| New | +$167K |
|
861
Travere Therapeutics
TVTX
$5.78B
| $207K | ﹤0.01% |
+23,041
| New | +$168K |
|
862
NETGEAR
NTGR
$635M
| $206K | ﹤0.01% |
+14,142
| New | +$183K |
|
|
VERV
863
DELISTED
Verve Therapeutics
VERV
| $205K | ﹤0.01% |
+14,741
| New | +$183K |
|
864
Covenant Logistics
CVLG
$872M
| $205K | ﹤0.01% |
+8,902
| New | +$191K |
|
|
GTY
865
Getty Realty Corp
GTY
$2.07B
| $205K | ﹤0.01% |
+7,013
| New | +$199K |
|
866
Albany International
AIN
$1.78B
| $204K | ﹤0.01% |
+2,081
| New | +$182K |
|
867
Bread Financial
BFH
$4.38B
| $204K | ﹤0.01% |
+6,194
| New | +$185K |
|
868
DXC Technology
DXC
$1.73B
| $204K | ﹤0.01% |
+8,904
| New | +$198K |
|
869
ON Semiconductor
ON
$31.6B
| $203K | ﹤0.01% |
+2,434
| New | +$191K |
|
870
Badger Meter
BMI
$4.03B
| $203K | ﹤0.01% |
+1,315
| New | +$192K |
|
|
HOUS
871
DELISTED
Anywhere Real Estate
HOUS
| $203K | ﹤0.01% |
+24,986
| New | +$142K |
|
872
Franklin Electric
FELE
$4.84B
| $202K | ﹤0.01% |
+2,090
| New | +$188K |
|
873
Federal Realty Investment Trust
FRT
$10.3B
| $201K | ﹤0.01% |
+1,953
| New | +$184K |
|
874
Embecta
EMBC
$262M
| $201K | ﹤0.01% |
+10,620
| New | +$174K |
|
875
Gentherm
THRM
$1.27B
| $201K | ﹤0.01% |
+3,836
| New | +$187K |
|
Similar funds
GKIM
DCP
VLKIM
ERSOT
GIM
DWM
MIFH
Brevan Howard Capital Management's Q4 2023 Portfolio in Review
As of Q4 2023, Brevan Howard Capital Management held 1,125 positions worth $8.18B, up 5.4% from $7.76B the previous quarter. Its ten largest holdings account for 80% of the portfolio.
Brevan Howard Capital Management's Q4 2023 filing shows 743 new, 197 increased, 52 reduced and 119 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 500,000 shares worth $38.7M. The largest sale was iShares MSCI Brazil ETF, an estimated $30.8M.
By sector, the portfolio is most concentrated in Technology at 1.7% of assets, up from 0.48% a quarter earlier, followed by Industrials and Consumer Discretionary.
- Brevan Howard Capital Management's largest Q4 2023 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 500,000 shares worth $38.7M.
- Brevan Howard Capital Management added most to iShares JPMorgan USD Emerging Markets Bond ETF in Q4 2023, an estimated $95.9M increase.
- Brevan Howard Capital Management's biggest Q4 2023 reduction was iShares MSCI Brazil ETF, cutting an estimated $30.8M.
- Brevan Howard Capital Management fully exited CME Group in Q4 2023, selling an estimated $20.5M.
- Brevan Howard Capital Management's ten largest holdings make up 80% of its $8.18B portfolio in Q4 2023.
- Brevan Howard Capital Management opened 743 new positions and closed 119 in Q4 2023.
- Brevan Howard Capital Management's portfolio value rose 5.4% quarter-over-quarter to $8.18B.
Based on Brevan Howard Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.